DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación
Artículo científico (JournalArticle)
Design, synthesis and structure-activity relationship (SAR) studies of an unusual class of non-cationic fatty amine-tripeptide conjugates as novel synthetic antimicrobial agents
Cationic ultrashort lipopeptides (USLPs) are promising antimicrobial candidates
to combat multidrug-resistant bacteria. Using DICAMs, a newly synthesized
family of tripeptides with net charges from −2 to +1 and a fatty amine
conjugated to the C-terminus, we demonstrate that anionic and neutral
zwitterionic USLPs can possess potent antimicrobial and membrane-
disrupting activities against prevalent human pathogens such as Streptococcus
pneumoniae and Streptococcus pyogenes. The strongest antimicrobials completely halt bacterial growth at low micromolar concentrations, reduce
bacterial survival by several orders of magnitude, and may kill planktonic cells
and biofilms. All of them comprise either an anionic or neutral zwitterionic peptide
attached to a long fatty amine (16–18 carbon atoms) and show a preference for
anionic lipid membranes enriched in phosphatidylglycerol (PG), which excludes
electrostatic interactions as the main driving force for DICAM action. Hence, the
hydrophobic contacts provided by the long aliphatic chains of their fatty amines are
needed for DICAM’s membrane insertion, while negative-charge shielding by salt
counterions would reduce electrostatic repulsions. Additionally, we show that
other components of the bacterial envelope, including the capsular
polysaccharide, can influence the microbicidal activity of DICAMs. Several
promising candidates with good-to-tolerable therapeutic ratios are identified as
potential agents against S. pneumoniae and S. pyogenes. Structural characteristics
that determine the preference for a specific pathogen or decrease DICAM toxicity
have also been investigated., The author(s) declare that financial support was received for the
research, authorship, and/or publication of this article. This work was
supported by grants of the Ministry of Science, Innovation and
Universities (RTI2018-099985-B-I00/AEI/10.13039/501100011033)
to MM and (PID2022-136307OB-C21/AEI/10.13039/
501100011033/FEDER, UE) to MC, SV, and SC, and by a grant
from the Ministry of Science and Innovation (PID2019-104070-RB-
C21) to MC, and SV. Additional funding was provided by the Centro
de Investigación Biomédica en Red de Enfermedades Respiratorias
(CIBERES), an initiative of the Instituto de Salud Carlos III (ISCIII) to
MM (CB06/06/1102) and MD (CB06/06/0003), and by Agencia
Estatal Consejo Superior de Investigaciones Científicas, CSIC,
(Projects CSIC-PIE201980E100, CSIC-PIE201980E028 and CSIC-
PIE202380E095) to MC, SV, and SC., Peer reviewed
Proyecto:
AEI / Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 RTI2018-099985-B-I00
,
AEI / Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023 PID2022-136307OB-C21
,
AEI / Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 PID2019-104070RB-C21